Hill-Rom predicts future growth following Trumpf acquisition

Hill-Rom has expressed confidence in its future growth prospects following the recent completion of its takeover of Trumpf Medical.

The company finalised the acquisition of the German manufacturer of operating room infrastructure products such as surgical tables, surgical lighting and supply units at the start of the month, more than doubling the size of its surgical portfolio.

As a result, Hill-Rom is now expecting to achieve revenue growth of between six and eight percent during the fourth quarter of its current fiscal year, building on the improvements it saw during the recently-completed third quarter.

According to the firm's latest financial data, revenue for the last three months saw a six percent year-on-year decline to $398 million (238.49 million pounds), but adjusted earnings per diluted share increased by four percent and reported earnings per diluted share jumped by 15 percent.

John Greisch, Hill-Rom's president and chief executive officer, said: "We are pleased to deliver adjusted earnings per share in line with our guidance, as well as expanded adjusted operating margin, despite continued revenue pressure across our portfolio."

It believes its current strategy of portfolio diversification, as exemplified by the Trumpf takeover, will help to drive its future success.